Eczas 1gm Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Ertapenem (1gm)
Overview Eczas 1gm Injection
Carbapenem antibiotic Eczas 1g Injection combats bacterial infections. Indicated for severe infections affecting the skin, respiratory system, gastrointestinal tract, urinary system, bloodstream, and central nervous system (including meningitis), it acts by eliminating causative bacteria. Primarily used in hospitalized patients with serious illnesses, administration is intravenous, either by infusion or direct injection, under medical supervision. Dosage is tailored to infection type, location, and severity. Continue the prescribed course, even with rapid symptom improvement; premature cessation risks relapse or infection exacerbation. Potential side effects include diarrhea, nausea, headache, and phlebitis. These are usually transient, resolving as the body adapts. Report persistent or bothersome side effects to your physician. Prior to treatment, disclose any epilepsy, hepatic or renal impairment, or antibiotic allergies. Blood tests to monitor hematologic parameters and renal function may be recommended during therapy. Generally considered safe during pregnancy and breastfeeding under medical guidance.
Uses of Eczas 1gm Injection
Life-threatening bacterial illnesses
Major Benefits of Eczas 1gm Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Eczas 1gm Injection:
- Infusion site inflammation
- Headache
- Vomiting
- Nausea
- Diarrhea
- Rash
- Dizziness
- Insomnia (difficulty in sleeping)
- Breathlessness
- Infusion site reaction
- Edema (swelling)
- Abdominal pain
- Disorientation (alteration of mental status)
- Vaginal inflammation
- Arrhythmia (irregular heartbeats)
How to use Eczas 1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Eczas 1gm Injection works:
Eczas 1gm Injection is a bactericidal antibiotic. Its mechanism of action involves disrupting bacterial cell wall synthesis, thereby eliminating the bacteria's protective barrier and leading to their death.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Eczas 1gm Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Eczas (1gm) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers may likely use Eczas 1gm Injection safely. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Administering Eczas 1gm Injection may induce adverse reactions impacting driving capabilities. Reported side effects, including drowsiness and dizziness, associated with Eczas 1gm Injection, could impair some patients' ability to operate vehicles or machinery.
KidneyCAUTION
Administering Eczas 1gm Injection to individuals with impaired renal function requires careful monitoring. Dosage modification of Eczas 1gm Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Eczas 1gm Injection poses no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Eczas 1gm Injection :
Should you forget a scheduled dose of Eczas 1gm Injection, seek medical advice.
Facts to Know About Eczas 1gm Injection
| Label | Value |
|---|---|
| Chemical Type | Carbapenem antibiotic |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
| Behavior Class | Carbapenem: Cell Wall-Targeting Agent |
3,018 People bought this recently